The overexpression of myosins has been reported in various cancers, including colorectal cancer [18–21], prostate cancer [22–27], breast cancer [28–30], ovarian cancer [31–32], melanoma [33–34], intestinal neoplasia [35–36], gastric cancer [37–38], pancreatic cancer [39–40], anaplastic gliomas [41] and acute myeloid leukemia [42]. Here, MYH14 is linked to prostate carcinoma.